Gundert-Remy U - Search Results

1

Modelling the genesis and treatment of cancer: the potential role of physiologically based pharmacodynamics.

Steimer JL, Dahl SG, De Alwis DP, Gundert-Remy U, Karlsson MO, Martinkova J, Aarons L, Ahr HJ, Clairambault J, Freyer G, Friberg LE, Kern SE, Kopp-Schneider A, Ludwig WD, De Nicolao G, Rocchetti M, Troconiz IF. Steimer JL, et al. Eur J Cancer. 2010 Jan;46(1):21-32. doi: 10.1016/j.ejca.2009.10.011. Eur J Cancer. 2010. PMID: 19954965

2

Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: a conceptual framework.

Dahl SG, Aarons L, Gundert-Remy U, Karlsson MO, Schneider YJ, Steimer JL, Trocóniz IF. Dahl SG, et al. Basic Clin Pharmacol Toxicol. 2010 Jan;106(1):2-12. doi: 10.1111/j.1742-7843.2009.00456.x. Epub 2009 Jul 22. Basic Clin Pharmacol Toxicol. 2010. PMID: 19686541 Review.

3

Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models.

Kapitulnik J, Pelkonen O, Gundert-Remy U, Dahl SG, Boobis AR. Kapitulnik J, et al. Expert Opin Ther Targets. 2009 Jul;13(7):867-87. doi: 10.1517/14728220903018965. Expert Opin Ther Targets. 2009. PMID: 19530989 Review.

4

Molecular approaches to the identification of biomarkers of exposure and effect--report of an expert meeting organized by COST Action B15. November 28, 2003.

Gundert-Remy U, Dahl SG, Boobis A, Kremers P, Kopp-Schneider A, Oberemm A, Renwick A, Pelkonen O. Gundert-Remy U, et al. Toxicol Lett. 2005 Apr 10;156(2):227-40. doi: 10.1016/j.toxlet.2004.11.016. Epub 2005 Jan 8. Toxicol Lett. 2005. PMID: 15737486 Review.

5

Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.

Stammschulte T, Ludwig WD, Mühlbauer B, Bronder E, Gundert-Remy U. Stammschulte T, et al. Eur J Clin Pharmacol. 2015 Sep;71(9):1129-38. doi: 10.1007/s00228-015-1895-y. Epub 2015 Jul 15. Eur J Clin Pharmacol. 2015. PMID: 26169297

6

The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Schott G, Pachl H, Limbach U, Gundert-Remy U, Lieb K, Ludwig WD. Schott G, et al. Dtsch Arztebl Int. 2010 Apr;107(17):295-301. doi: 10.3238/arztebl.2010.0295. Epub 2010 Apr 30. Dtsch Arztebl Int. 2010. PMID: 20490338 Free PMC article.

7

The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig WD, Lieb K. Schott G, et al. Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23. Dtsch Arztebl Int. 2010. PMID: 20467553 Free PMC article.

8

Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes.

Schug M, Stöber R, Heise T, Mielke H, Gundert-Remy U, Godoy P, Reif R, Blaszkewicz M, Ellinger-Ziegelbauer H, Ahr HJ, Selinski S, Günther G, Marchan R, Blaszkewicz M, Sachinidis A, Nüssler A, Oberemm A, Hengstler JG. Schug M, et al. Arch Toxicol. 2013 Feb;87(2):337-45. doi: 10.1007/s00204-012-0999-8. Epub 2012 Dec 29. Arch Toxicol. 2013. PMID: 23274394

9

Differential signatures of protein expression in marmoset liver and thymus induced by single-dose TCDD treatment.

Oberemm A, Meckert C, Brandenburger L, Herzig A, Lindner Y, Kalenberg K, Krause E, Ittrich C, Kopp-Schneider A, Stahlmann R, Richter-Reichhelm HB, Gundert-Remy U. Oberemm A, et al. Toxicology. 2005 Jan 5;206(1):33-48. doi: 10.1016/j.tox.2004.06.061. Toxicology. 2005. PMID: 15590107

10

Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: comparison of genomic and proteomic responses and anchoring to histopathological parameters.

Oberemm A, Ahr HJ, Bannasch P, Ellinger-Ziegelbauer H, Glückmann M, Hellmann J, Ittrich C, Kopp-Schneider A, Kramer PJ, Krause E, Kröger M, Kiss E, Richter-Reichhelm HB, Scholz G, Seemann K, Weimer M, Gundert-Remy U. Oberemm A, et al. Toxicol Appl Pharmacol. 2009 Dec 1;241(2):230-45. doi: 10.1016/j.taap.2009.08.020. Epub 2009 Aug 28. Toxicol Appl Pharmacol. 2009. PMID: 19716841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters